登录 注册 会员服务 联系我们

Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy

  • Published:2022-03-18 Issue:2 Volume:193 Page:393-403
  • ISSN:0167-6806
  • Container-title:Breast Cancer Research and Treatment
  • language:en
  • Short-container-title:Breast Cancer Res Treat

Author:

Tan Qixing,Qin Qinghong,Huang Zhen,Lian Bin,Mo Qinguo,Wei ChangyuanORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangxi Province

the Youth Program of Scientific Research Foundation of Guangxi Medical University Cancer Hospital

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference42 articles.

1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144:1941–1953. https://doi.org/10.1002/ijc.31937

2. Spring L, Greenup R, Niemierko A, Schapira L, Haddad S, Jimenez R, Coopey S, Taghian A, Hughes KS, Isakoff SJ, Ellisen LW, Smith BL, Specht M, Moy B, Bardia A (2017) Pathologic complete response after neoadjuvant chemotherapy and long-term outcomes among young women with breast cancer. J Natl Compr Cancer Netw: JNCCN 15:1216–1223. https://doi.org/10.6004/jnccn.2017.0158

3. Ang E, Wewala N, Carroll R, Forgeson G, Anderson M, Fernando J, Jordan J, Isaacs R (2020) Neoadjuvant chemotherapy in non-metastatic breast cancer: a study on practice trends in a regional cancer treatment service. Intern Med J 50:315–321. https://doi.org/10.1111/imj.14326

4. Shin HC, Han W, Moon HG, Im SA, Moon WK, Park IA, Park SJ, Noh DY (2013) Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients. Ann Surg Oncol 20:2582–2589. https://doi.org/10.1245/s10434-013-2909-6

5. Chaudry M, Lei X, Gonzalez-Angulo AM, Mittendorf EA, Valero V, Tripathy D, Hortobagyi GN, Chavez-MacGregor M (2015) Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 153:417–423. https://doi.org/10.1007/s10549-015-3533-x

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3